Literature DB >> 30602788

Genomic insights into the 2016-2017 cholera epidemic in Yemen.

François-Xavier Weill1, Daryl Domman2,3, Nicholas R Thomson2,4, Marie-Laure Quilici5, Elisabeth Njamkepo5, Abdullrahman A Almesbahi6, Mona Naji6, Samar Saeed Nasher6, Ankur Rakesh7, Abdullah M Assiri8, Naresh Chand Sharma9, Samuel Kariuki10, Mohammad Reza Pourshafie11, Jean Rauzier5, Abdinasir Abubakar12, Jane Y Carter13, Joseph F Wamala14, Caroline Seguin15, Christiane Bouchier16, Thérèse Malliavin17, Bita Bakhshi18, Hayder H N Abulmaali19, Dhirendra Kumar9,20, Samuel M Njoroge10, Mamunur Rahman Malik12, John Kiiru10, Francisco J Luquero7, Andrew S Azman21, Thandavarayan Ramamurthy20.   

Abstract

Yemen is currently experiencing, to our knowledge, the largest cholera epidemic in recent history. The first cases were declared in September 2016, and over 1.1 million cases and 2,300 deaths have since been reported1. Here we investigate the phylogenetic relationships, pathogenesis and determinants of antimicrobial resistance by sequencing the genomes of Vibrio cholerae isolates from the epidemic in Yemen and recent isolates from neighbouring regions. These 116 genomic sequences were placed within the phylogenetic context of a global collection of 1,087 isolates of the seventh pandemic V. cholerae serogroups O1 and O139 biotype El Tor2-4. We show that the isolates from Yemen that were collected during the two epidemiological waves of the epidemic1-the first between 28 September 2016 and 23 April 2017 (25,839 suspected cases) and the second beginning on 24 April 2017 (more than 1 million suspected cases)-are V. cholerae serotype Ogawa isolates from a single sublineage of the seventh pandemic V. cholerae O1 El Tor (7PET) lineage. Using genomic approaches, we link the epidemic in Yemen to global radiations of pandemic V. cholerae and show that this sublineage originated from South Asia and that it caused outbreaks in East Africa before appearing in Yemen. Furthermore, we show that the isolates from Yemen are susceptible to several antibiotics that are commonly used to treat cholera and to polymyxin B, resistance to which is used as a marker of the El Tor biotype.

Entities:  

Mesh:

Year:  2019        PMID: 30602788      PMCID: PMC6420076          DOI: 10.1038/s41586-018-0818-3

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  40 in total

1.  Insights into TLCΦ lysogeny: A twist in the mechanism of IMEX integration.

Authors:  Bhabatosh Das
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-22       Impact factor: 11.205

2.  A Point Mutation in carR Is Involved in the Emergence of Polymyxin B-Sensitive Vibrio cholerae O1 El Tor Biotype by Influencing Gene Transcription.

Authors:  Prosenjit Samanta; Rahul Shubhra Mandal; Rudra Narayan Saha; Sreeja Shaw; Priyanka Ghosh; Shanta Dutta; Amit Ghosh; Daisuke Imamura; Masatomo Morita; Makoto Ohnishi; Thandavarayan Ramamurthy; Asish Kumar Mukhopadhyay
Journal:  Infect Immun       Date:  2020-04-20       Impact factor: 3.441

3.  Functional characterization of a subtilisin-like serine protease from Vibrio cholerae.

Authors:  Matthew Howell; Daniel G Dumitrescu; Lauren R Blankenship; Darby Herkert; Stavroula K Hatzios
Journal:  J Biol Chem       Date:  2019-05-10       Impact factor: 5.157

4.  Dissecting serotype-specific contributions to live oral cholera vaccine efficacy.

Authors:  Brandon Sit; Bolutife Fakoya; Ting Zhang; Gabriel Billings; Matthew K Waldor
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-16       Impact factor: 11.205

5.  Vibrio cholerae O139 genomes provide a clue to why it may have failed to usher in the eighth cholera pandemic.

Authors:  Thandavarayan Ramamurthy; Agila Kumari Pragasam; Alyce Taylor-Brown; Robert C Will; Karthick Vasudevan; Bhabatosh Das; Sunil Kumar Srivastava; Goutam Chowdhury; Asish K Mukhopadhyay; Shanta Dutta; Balaji Veeraraghavan; Nicholas R Thomson; Naresh C Sharma; Gopinath Balakrish Nair; Yoshifumi Takeda; Amit Ghosh; Gordon Dougan; Ankur Mutreja
Journal:  Nat Commun       Date:  2022-07-05       Impact factor: 17.694

6.  Molecular insights into the genome dynamics and interactions between core and acquired genomes of Vibrio cholerae.

Authors:  Archana Pant; Satyabrata Bag; Bipasa Saha; Jyoti Verma; Pawan Kumar; Sayantan Banerjee; Bhoj Kumar; Yashwant Kumar; Anbumani Desigamani; Suhrid Maiti; Tushar K Maiti; Sanjay K Banerjee; Rupak K Bhadra; Hemanta Koley; Shanta Dutta; G Balakrish Nair; Thandavarayan Ramamurthy; Bhabatosh Das
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-01       Impact factor: 11.205

Review 7.  Zebrafish Models for Pathogenic Vibrios.

Authors:  Dhrubajyoti Nag; Dustin A Farr; Madison G Walton; Jeffrey H Withey
Journal:  J Bacteriol       Date:  2020-11-19       Impact factor: 3.490

8.  A Vibrio cholerae Core Genome Multilocus Sequence Typing Scheme To Facilitate the Epidemiological Study of Cholera.

Authors:  Kevin Y H Liang; Fabini D Orata; Mohammad Tarequl Islam; Tania Nasreen; Munirul Alam; Cheryl L Tarr; Yann F Boucher
Journal:  J Bacteriol       Date:  2020-11-19       Impact factor: 3.490

9.  Severe dehydration among cholera patients in Yemen: A cohort profile.

Authors:  Mohammed M Alassar; Oyelola A Adegboye; Theophilus I Emeto; Kazi M Rahman; Lawal Olumuyiwa Mashood; Faiz Am Elfaki
Journal:  Germs       Date:  2020-12-28

10.  Recent Vibrio cholerae O1 Epidemic Strains Are Unable To Replicate CTXΦ Prophage Genome.

Authors:  Kaoru Ochi; Tamaki Mizuno; Prosenjit Samanta; Asish K Mukhopadhyay; Shin-Ichi Miyoshi; Daisuke Imamura
Journal:  mSphere       Date:  2021-06-09       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.